How can we improve the management of adult-onset Still's disease?

Joint Bone Spine

Volumn 74, Issue 2, 2007, Pages 117-119

  Pouchot, Jacques ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADALIMUMAB; ATLIZUMAB; AZATHIOPRINE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; FERRITIN; GLUCOCORTICOID; GOLD; IMMUNOGLOBULIN; INFLIXIMAB; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT ONSET STILL DISEASE; CLINICAL TRIAL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDICATION; EDITORIAL; HUMAN; INFLAMMATORY DISEASE; LOW DRUG DOSE; PATHOPHYSIOLOGY; RHEUMATOID ARTHRITIS;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; EVIDENCE-BASED MEDICINE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; STILL'S DISEASE, ADULT-ONSET;

EID: 34247168104     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2006.07.003     Document Type: Editorial

References (26)

1. Bywaters E.G.L. Still's disease in the adult. Ann Rheum Dis 30 (1971) 121-133
2. Pouchot J., Kahn M.F., and Vinceneux P. Maladie de Still de l'adulte. In: Kahn M.F., Peltier A.P., Meyer O., and Piette J.C. (Eds). Maladies et syndromes systémiques (2000), Médecine-Sciences, Flammarion 449-468
3. Yamaguchi M., Ohta A., Tsunematsu T., Kasukawa R., Mizushima Y., Kashiwagi H., et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 19 (1992) 424-430
4. Fautrel B., Zing E., Golmard J.L., Le Moel G., Bissery A., Rioux C., et al. Proposal for a new set of classification criteria for adult-onset Still's disease. Medicine (Baltimore) 81 (2002) 194-200
5. Fautrel B., Le Moel G., Saint-Marcoux B., Taupin P., Vignes S., Rozenberg S., et al. Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease. J Rheumatol 28 (2001) 322-329
6. Pouchot J, Vinceneux P. Maladie de Still de l'adulte. In: Bardin T, editor. Thérapeutique Rhumatologique. Médecine-Sciences, Flammarion (sous presse); 2007.
7. Koizumi R., Tsukada Y., Ideura H., Ueki K., Maezawa A., and Nojima Y. Treatment of adult Still's disease with dexamethasone, an alternative to prednisolone. Scand J Rheumatol 29 (2000) 396-398
8. Sampalis J.S., Esdaile J.M., Medsger Jr. T.A., Partridge A.J., Yeadon C., Senecal J.L., et al. A controlled study of the long-term prognosis of adult Still's disease. Am J Med 98 (1995) 384-388
9. Fautrel B., Borget C., Rozenberg S., Meyer O., Le Loet X., Masson C., et al. Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease. J Rheumatol 26 (1999) 373-378
10. Pirildar T. Treatment of adult-onset Still's disease with leflunomide and chloroquine combination in two patients. Clin Rheumatol 22 (2003) 157
11. Jung J.H., Jun J.B., Yoo D.H., Kim T.H., Jung S.S., Lee I.H., et al. High toxicity of sulfasalazine in adult-onset Still's disease. Clin Exp Rheumatol 18 (2000) 245-248
12. Permal S., Wechsler B., Cabane J., Perrot S., Blum L., and Imbert J.C. Traitement de la maladie de Still de l'adulte par immunoglobulines intraveineuses. Rev Med Interne 16 (1995) 250-254
13. Vignes S., Wechsler B., Amoura Z., Papo T., Francès C., Huong D.L., et al. Intravenous immunoglobulin in adult Still's disease refractory to non-steroidal anti-inflammatory drugs. Clin Exp Rheumatol 16 (1998) 295-298
14. Choi J.H., Suh C.H., Lee Y.M., Su Y.J., Lee S.K., Kim S.S., et al. Serum cytokine profiles in patients with adult onset Still's disease. J Rheumatol 30 (2003) 2422-2427
15. Fautrel B., Sibilia J., Mariette X., and Combe B. the Club Rhumatismes et Inflammation. Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases. Ann Rheum Dis 64 (2005) 262-266
16. Fitzgerald A.A., LeClercq S.A., Yan A., Homik J.E., and Dinarello C.A. Rapid responses to anakinra in patients with refractory adult-onset Still's disease. Arthritis Rheum 52 (2005) 1794-1803
17. Serratrice J., Granel B., Disdier P., Weiller P.J., and Dussol B. Resolution with etanercept of nephrotic syndrome due to renal AA amyloidosis in adult Still's disease. Am J Med 115 (2003) 589-590
18. Chouc P.Y., Nicoud-Lepore A., and Jeandel P. Maladie de Still de l'adulte: une appellation à contrôler. Rev Rhum Mal Osteoartic 63 (1996) 463-465
19. Pouchot J. Peut-on encore parler de syndrome de Wissler-Fanconi?. Rev Med Interne 23 (2002) 257-258
20. Halpern S.D., Karlawish J.H.T., and Berlin J.A. The continuing unethical conduct of underpowered clinical trials. JAMA 288 (2002) 358-362
21. Edwards S.J.L., Lilford R.J., Braunholtz D., and Jackson J. Why "underpowered" trials are not necessarily unethical. Lancet 350 (1997) 804-807
22. Lilford R.J., Thornton G., and Braunholtz D. Clinical trials and rare diseases: a way out of a conundrum. BMJ 311 (1995) 1621-1625
23. Arlet J.B., Boutin-Le Thi Huong D., Pouchot J., and Piette J.C. Physiopathologie de la maladie de Still de l'adulte. Rev Med Interne 26 (2005) 549-556
24. Yokota S., Miyamae T., Imagawa T., Iwata N., Katakura S., Mori M., et al. Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 52 (2005) 818-825
25. Woo P., Wilkinson N., Prieur A.M., Southwood T., Leone W., Livermore P., et al. Open label phase II trial of single, ascending dose of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement. Arthritis Res Ther 7 (2005) 1281-1288
26. Iwamoto M., Nara H., Hirata D., Minota S., Nishimoto N., and Yoshizaki K. Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still's disease. Arthritis Rheum 46 (2002) 3388-3389